| 0.932 | 0.003 | 0.932 | Hypolipemic | | |
| 0.727 | 0.001 | 0.727 | HMG CoA reductase inhibitor | | |
| 0.529 | 0.002 | 0.529 | Cholesterol synthesis inhibitor | | |
| 0.521 | 0.024 | 0.521 | Vasodilator, peripheral | | |
| 0.485 | 0.015 | 0.485 | Platelet antagonist | | |
| 0.471 | 0.059 | 0.471 | Cyclophilin D inhibitor | | |
| 0.373 | 0.057 | 0.373 | Antithrombotic | | |
| 0.316 | 0.004 | 0.316 | Prostaglandin EP2 antagonist | | |
| 0.344 | 0.067 | 0.344 | Cholesterol antagonist | | |
| 0.367 | 0.105 | 0.367 | Calcium channel L-type activator | | |
| 0.315 | 0.066 | 0.315 | Sodium/bile acid cotransporter inhibitor | | |
| 0.243 | 0.004 | 0.243 | Leukotriene antagonist | | |
| 0.311 | 0.078 | 0.311 | Apoptosis antagonist | | |
| 0.316 | 0.087 | 0.316 | Transcription factor NF kappa B inhibitor | | |
| 0.267 | 0.044 | 0.267 | Platelet adhesion inhibitor | | |
| 0.243 | 0.028 | 0.243 | NOS3 expression enhancer | | |
| 0.256 | 0.073 | 0.256 | Hypoglycemic | | |
| 0.202 | 0.035 | 0.202 | Bone formation stimulant | | |
| 0.237 | 0.077 | 0.237 | Vasodilator | | |
| 0.155 | 0.004 | 0.155 | Prostaglandin F2 alpha antagonist | | |
| 0.186 | 0.044 | 0.186 | Insulin secretagoues | | |
| 0.145 | 0.004 | 0.145 | Prostaglandin EP3 antagonist | | |
| 0.139 | 0.004 | 0.139 | Prostaglandin agonist | | |
| 0.203 | 0.071 | 0.203 | Insulin sensitizer | | |
| 0.148 | 0.022 | 0.148 | Toll-Like receptor 4 antagonist | | |
| 0.149 | 0.026 | 0.149 | Catalase inhibitor | | |
| 0.246 | 0.124 | 0.246 | Interleukin 2 agonist | | |
| 0.261 | 0.14 | 0.261 | Immunosuppressant | | |
| 0.124 | 0.006 | 0.124 | Thromboxane antagonist | | |
| 0.182 | 0.078 | 0.182 | Hepatoprotectant | | |
| 0.116 | 0.012 | 0.116 | Prostaglandin E2 antagonist | | |
| 0.197 | 0.096 | 0.197 | Angiogenesis stimulant | | |
| 0.107 | 0.009 | 0.107 | Leukotriene B4 antagonist | | |
| 0.1 | 0.004 | 0.1 | Prostaglandin E2 agonist | | |
| 0.11 | 0.015 | 0.11 | Prostaglandin antagonist | | |
| 0.101 | 0.007 | 0.101 | Thromboxane A2 antagonist | | |
| 0.177 | 0.09 | 0.177 | Non-steroidal antiinflammatory agent | | |
| 0.173 | 0.086 | 0.173 | P-glycoprotein inhibitor | | |
| 0.153 | 0.075 | 0.153 | Interferon gamma antagonist | | |
| 0.19 | 0.118 | 0.19 | Tumour necrosis factor alpha release inhibitor | | |
| 0.087 | 0.016 | 0.087 | Nitric oxide donor | | |
| 0.109 | 0.039 | 0.109 | ABCA1 expression enhancer | | |
| 0.194 | 0.126 | 0.194 | Interleukin agonist | | |
| 0.19 | 0.122 | 0.19 | Antioxidant | | |
| 0.071 | 0.006 | 0.071 | Prostaglandin EP4 antagonist | | |
| 0.063 | 0.004 | 0.063 | Prostaglandin EP2 agonist | | |
| 0.058 | 0.005 | 0.058 | Prostaglandin D2 agonist | | |
| 0.055 | 0.004 | 0.055 | Prostacyclin agonist | | |
| 0.096 | 0.045 | 0.096 | ATPase (Vacuolar H+) inhibitor | | |
| 0.086 | 0.036 | 0.086 | Peroxisome proliferator-activated receptor gamma agonist | | |
| 0.057 | 0.008 | 0.057 | Glucagon receptor antagonist | | |
| 0.052 | 0.005 | 0.052 | Prostaglandin EP4 agonist | | |
| 0.073 | 0.027 | 0.073 | Cathepsin E inhibitor | | |
| 0.104 | 0.058 | 0.104 | Folate antagonist | | |
| 0.145 | 0.1 | 0.145 | Nitric oxide antagonist | | |
| 0.067 | 0.023 | 0.067 | Peroxisome proliferator-activated receptor alpha agonist | | |
| 0.045 | 0.018 | 0.045 | Glucagon-like peptide 1 receptor antagonist | | |
| 0.059 | 0.033 | 0.059 | Leukotriene C antagonist | | |
| 0.038 | 0.015 | 0.038 | Cholesterol ester transfer protein antagonist | | |
| 0.132 | 0.109 | 0.132 | Melanin inhibitor | | |
| 0.034 | 0.015 | 0.034 | Leukotriene B4 receptor 1 antagonist | | |
| 0.029 | 0.01 | 0.029 | Prostaglandin EP1 antagonist | | |
| 0.139 | 0.123 | 0.139 | Lipocortins synthesis antagonist | | |
| 0.079 | 0.064 | 0.079 | Thioredoxin reductase inhibitor | | |
| 0.06 | 0.047 | 0.06 | Caspase 9 inhibitor | | |
| 0.021 | 0.009 | 0.021 | Free fatty acid receptor 1 agonist | | |
| 0.146 | 0.134 | 0.146 | Platelet aggregation inhibitor | | |
| 0.033 | 0.023 | 0.033 | Prostacyclin antagonist | | |
| 0.064 | 0.06 | 0.064 | HIV-1 integrase inhibitor | | |
| 0.037 | 0.033 | 0.037 | Leukotriene C4 antagonist | | |
| 0.021 | 0.017 | 0.021 | Leukotriene B4 receptor 2 antagonist | | |
| 0.083 | 0.08 | 0.083 | Glutamate release inhibitor | | |